Evercore ISI Upgrades Avidity Biosciences (RNA) to Outperform, 'Valuation Better Reflects Risks'
Tweet Send to a Friend
(Updated - May 22, 2023 6:42 AM EDT)
Evercore ISI analyst Josh Schimmer upgraded Avidity Biosciences (NASDAQ: RNA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Evercore ISI analyst Josh Schimmer upgraded Avidity Biosciences (NASDAQ: RNA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
